2019
DOI: 10.1007/s10865-018-9981-0
|View full text |Cite
|
Sign up to set email alerts
|

Key milestones during 40 years of behavioral medicine at the National Institutes of Health

Abstract: The National Institutes of Health (NIH) has played a major role in promoting behavioral medicine research over the past 40 years through funding, review, and priority-setting activities and programs including scientific conferences, meetings, workgroups, intramural research, and training opportunities. In this review of NIH activities in support of behavioral medicine over the past four decades, we highlight key events, programs, projects, and milestones that demonstrate the many ways in which the NIH has supp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 71 publications
0
2
0
Order By: Relevance
“…It takes many different kinds of studies to improve health outcomes, but rigorous Phase III trials are the definitive testbeds for health-related behavioral interventions; progress toward better outcomes depends on them (Czajkowski et al, 2015(Czajkowski et al, , 2019Mensah & Czajkowski, 2018). They are as essential for making progress in behavioral research as pivotal Phase III trials are in pharmaceutical research (Darrow et al, 2020).…”
Section: Lack Of Outcome-oriented Trialsmentioning
confidence: 99%
“…It takes many different kinds of studies to improve health outcomes, but rigorous Phase III trials are the definitive testbeds for health-related behavioral interventions; progress toward better outcomes depends on them (Czajkowski et al, 2015(Czajkowski et al, , 2019Mensah & Czajkowski, 2018). They are as essential for making progress in behavioral research as pivotal Phase III trials are in pharmaceutical research (Darrow et al, 2020).…”
Section: Lack Of Outcome-oriented Trialsmentioning
confidence: 99%
“…Cardiovascular behavioral medicine research has made significant advances over the past 50 years (Czajkowski et al, 2019). From the earliest studies showing the role of type A behavior on cardiovascular disease (CVD) risk (Rosenman & Friedman, 1977) to more recent discoveries demonstrating the impact of chronic experiences with ethnic and racial discrimination on cardiovascular disease (Brewer & Cooper, 2014), the field of cardiovascular behavioral medicine has led the way in discovery of the fundamental role of behavioral and psychosocial factors on the most common causes of death and disease in the United States.…”
mentioning
confidence: 99%